SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
258>>You may be correct (nothing to move it, near term) and Garren may look lIcebrg-6/2/2003
257>> It is difficult to see anything that will move the share price short-tescaram(o)uche-6/2/2003
256down 25%. he certainly has a hot-money following. thanks for the detail. --Wikeokalani'nui-6/2/2003
255<Garren selling> Yes, he wrote: <i>Selling 3000 shares Kosan (KOSNIcebrg-6/2/2003
254I hear garren put a sell on it. The guy has a following it appears. He'll keokalani'nui-6/2/2003
253Given that the likely dose for the EpoD PII will be almost 3x the EpoB dose, it tuck-6/2/2003
252Bristol-Myers Squibb Epothilone Phase II Findings Show Activity in Metastatic Brscaram(o)uche-6/2/2003
251Also, 17-AAG with Velcade: Message 18991361 Cheers, Tucktuck-6/1/2003
250A couple of AACR abstracts of interest: >>KOS-862 (Epothilone D) with 5-Ftuck-5/28/2003
249CIBC presentation. I think this presentation is well worth listening to. It is Icebrg-5/10/2003
248So much so, Erik, that KOSN made Briefing's week end hit parade. Pity that itom pope-4/25/2003
247Someone has found out about Kosan. Now, I would just like to know what they thinIcebrg-4/25/2003
246Thanks, WE, that makes sensetom pope-4/25/2003
245<i>I was wondering whether they had a means of cash generation that did nokeokalani'nui-4/25/2003
244I agree, and when I saw the number I was wondering whether they had a means of ctom pope-4/24/2003
243What surprised me more than anything else in the report was the following. <Icebrg-4/24/2003
242Kosan Reports First Quarter Financial Results Thursday April 24, 7:31 am ET 3-scaram(o)uche-4/24/2003
241<i>10-K filed today...... "expect to enter Phase II human clinical trkeokalani'nui-3/30/2003
240>>Cancer Res 2002 Oct 15;62(20):5761-9 Molecular characterization and setuck-3/28/2003
239>> Umm, what did he say about it? << I was having trouble with keepscaram(o)uche-3/28/2003
238Umm, what did he say about it? >>Blood 2003 Mar 6; [epub ahead of print] tuck-3/28/2003
237<i>Geldanamycin Hsp90 (heat shock protein 90) is a protein chaperone thascaram(o)uche-3/28/2003
236>> Did they give any hints as to timing of commencement of EpoD PII trialsscaram(o)uche-3/28/2003
235"Thank you for your interest in this event. The live presentation is currenscaram(o)uche-3/28/2003
234>> Some people on Earth have pride. << BTW, I've never mentionescaram(o)uche-3/28/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News